AnaptysBio Reports Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps

NEXT STORY
Global In-vitro Diagnostics Market Expected to Garner $104.1 Billion by 2027 Despite the COVID-19 Global Outbreak – Exclusive Report [220 pages] by Research Dive
PREV STORY
Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

23andMe Reports FY2022 First Quarter Financial Results

author_avatar
NASDAQ Market News

XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks

Findings Demonstrate Ability of MABp1 (Bermekimab) to Block In Vitro Neutrophil Mediated Vascular Endothelial ...

author_avatar
NASDAQ Market News

SCYNEXIS Announces Hansoh Pharma’s Application to National Medical Products Administration (NMPA) in China for Phase 3 Trial of Ibrexafungerp for Treatment of Vulvovaginal Candidiasis (VVC)

author_avatar
NASDAQ Market News